期刊文献+

脑血栓患者活化蛋白C抵抗及Fg、AT-和PC的变化 被引量:5

Preliminary study of the activated protein C resistance and the levels of Fg, AT[HT5”,5SS]Ⅲ and PC in patients with cerebral thrombosis.
下载PDF
导出
摘要 本文对脑血栓患者 6 0例和健康人 30名研究其血中活化蛋白 C抵抗 (APCR)、纤维蛋白原 (Fg)、抗凝血酶 (AT- )和蛋白 C(PC)的变化。结果表明 ,患者 Fg含量、AT- 活性和 PC活性均高于对照组。而其 APCR发生率为 8.3%也高于对照组 ,表明脑血栓患者可能存在 Thirty healthy controls and sixty cerebral thrombosis patients were studied on the change of activated protein C resistance (APCR), fibrinogen, antithrombin [HT5”,5SS]Ⅲ and protein C. The results showed the level of Fg, and activities of AT[HT5”,5SS]Ⅲ and PC in patients were higher than in healthy controls. The incidence of APCR in patients was 8 3%. There might exist APCR in some patients with cerebral thrombosis.
出处 《上海医学检验杂志》 2000年第2期83-84,共2页 Shanghai Journal of Medical Laboratory Sciences
关键词 脑血栓 活化蛋白C抵抗 纤维蛋白原 抗凝血酶Ⅱ Cerebral thrombosis Activated protein C resistance Fibrinogen Anti thrombin [HT5”,5SS]Ⅲ Protein C
  • 相关文献

参考文献2

二级参考文献3

  • 1储海燕 诸江 等.上海地区深静脉血栓形成患者抗活化的蛋白C和FV Leiden突变的初步调查[J].中华血液学杂志,1996,17:462-465.
  • 2Sun X,Blood,1994年,83卷,3120页
  • 3储海燕,中华血液学杂志,1996年,17卷,462页

共引文献36

同被引文献26

  • 1薛敏.活血化瘀法治疗高粘血症并高脂血症45例[J].中国中医急症,2004,13(8):529-529. 被引量:1
  • 2王义军,赵波.路路通注射液治疗糖尿病高脂血症的疗效观察[J].心血管康复医学杂志,1999,8(B12):144-145. 被引量:2
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33024
  • 4王秋萍 张学勤.715例脑梗塞患者血液流变学观察[J].临床检验杂志,2000,18(1):62-62.
  • 5VIKTOROV I V. The role of nitric oxide and other free radicals in ischemic brain pathology[J]. Vestn Ross Akad Med NauK,2000,4:5 - 10.
  • 6VLASOV T D, VIVULANETS E V, MINDUKSHEV I V, et al. Functional activity of blood platelets during cerebral ischemid/reperfusion in rats[J]. Ros Fiziol Zh Im IM Sechenova,2000,86(4):422- 426.
  • 7王维治.神经病学[M].北京:人民卫生出版社,2002.142-147.
  • 8Bick RL. Antiphospholipid thrombosis syndromes: etiology pathophysiology,diagnosis and management[ J]. Intemational J Hematol, 1997,65:193.
  • 9Lechner K, Pabinger- Fasching 1. upus anticoagulant and thrombosis [J].Haemostasis, 1985,15: 254.
  • 10Potzsch B, Kawamura H,Preissner KT, et al. Acquired protein C dyfunction but not decreased activity of TM is a possible marker of thrombophilia in patients with lupus anticoagulants[J]. Lab Clin Med, 1995,125:56.

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部